Unlock stock picks and a broker-level newsfeed that powers Wall Street.
ASX - Delayed Quote AUD

The Calmer Co International Limited (CCO.AX)

Compare
0.0050
0.0000
(0.00%)
At close: April 4 at 2:59:56 PM GMT+11
Loading Chart for CCO.AX
  • Previous Close 0.0050
  • Open 0.0050
  • Bid 0.0040 x --
  • Ask 0.0050 x --
  • Day's Range 0.0050 - 0.0050
  • 52 Week Range 0.0040 - 0.0200
  • Volume 11,265,066
  • Avg. Volume 2,061,094
  • Market Cap (intraday) 12.769M
  • Beta (5Y Monthly) 1.38
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date Feb 28, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

The Calmer Co International Limited operates as a health and wellness company in Australia, Fiji, the United States, and internationally. It produces and sells powdered drinking kava, teas, and capsules under the FijiKava brand name; cold pressed shots and kava under the Taki Mai brand name; hemp, CBD oils, topical products, and kava tinctures under Danodan brand name; and nutraceuticals. It also markets Leilo kava beverages. In addition, it sells its products through retailers and online. The company was formerly known as Fiji Kava Limited and changed its name to The Calmer Co International Limited in April 2023. The Calmer Co International Limited was incorporated in 2014 and is based in West End, Australia.

www.thecalmerco.com

--

Full Time Employees

June 30

Fiscal Year Ends

Recent News: CCO.AX

View More

Performance Overview: CCO.AX

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .

YTD Return

CCO.AX
16.67%
S&P/ASX 200 [XJO] (^AXJO)
6.02%

1-Year Return

CCO.AX
25.03%
S&P/ASX 200 [XJO] (^AXJO)
1.36%

3-Year Return

CCO.AX
92.75%
S&P/ASX 200 [XJO] (^AXJO)
2.05%

5-Year Return

CCO.AX
92.19%
S&P/ASX 200 [XJO] (^AXJO)
51.31%

Compare To: CCO.AX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CCO.AX

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    12.77M

  • Enterprise Value

    12.91M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.27

  • Price/Book (mrq)

    6.05

  • Enterprise Value/Revenue

    1.79

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -61.80%

  • Return on Assets (ttm)

    -56.82%

  • Return on Equity (ttm)

    -548.03%

  • Revenue (ttm)

    7.2M

  • Net Income Avi to Common (ttm)

    -4.45M

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.16M

  • Total Debt/Equity (mrq)

    108.75%

  • Levered Free Cash Flow (ttm)

    -3.69M

Research Analysis: CCO.AX

View More

Company Insights: CCO.AX

Research Reports: CCO.AX

View More

People Also Watch